Neuropharmacological Review of the Nootropic Herb Bacopa Monnieri. Rejuvenation Research, vol
Despite the objective improvements, only 26.7% (Group A) and 14.3% (Group B) rated results "good" or "excellent." This highlights the gap between measurable hair count increases and subjective satisfaction patients often need to see dramatic visual change to feel satisfied, which may require longer treatment or combination approaches
doi: 10.1038/s41598-023-32257-5 37 ZhangYFuXJiaJWikerholmenTXiKKongYet al
Michael was great to work with
Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline
Fras, M